Notoriously tricky to detect, pancreatic cancer also often resists traditional therapy. So, researchers are urgently looking ...

By targeting a cancer-driving pathway at multiple steps, a triple therapy stopped pancreatic tumors from developing ...

Researchers found that nerves and cancer-supporting cells team up early to drive pancreatic cancer—breaking that alliance could weaken the disease before it fully forms.

Cold Spring Harbor Laboratory postdoc Jeremy Nigri and colleagues in the Tuveson lab have discovered that the nervous system ...

Current drugs for pancreatic cancer lose effectiveness within months because the tumour becomes resistant. The group from ...

Pancreas development in pigs resembles humans much more closely than does the established mouse model. An international team headed by Helmholtz Munich and the German Center for Diabetes Research (DZD ...

Hans Clevers, PhD, has been working on organoids from the beginning. He was group leader for twenty years at the Hubrecht Institute and has been head of pharma research and early development (pRED) of ...

Researchers at the University of Helsinki, Finland, have uncovered a mechanism through which a mutation in the STAT3 gene leads to a disorder in the development of the pancreas and to infant diabetes.

Current drugs for pancreatic cancer lose effectiveness within months because the tumor becomes resistant. Now, a group from ...

Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.